Structure

Physi-Chem Properties

Molecular Weight:  432.25
Volume:  454.846
LogP:  3.125
LogD:  2.609
LogS:  -3.699
# Rotatable Bonds:  5
TPSA:  111.13
# H-Bond Aceptor:  6
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.569
Synthetic Accessibility Score:  5.246
Fsp3:  0.64
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.58
MDCK Permeability:  1.0988270332745742e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.022
Human Intestinal Absorption (HIA):  0.026
20% Bioavailability (F20%):  0.048
30% Bioavailability (F30%):  0.116

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.121
Plasma Protein Binding (PPB):  95.66765594482422%
Volume Distribution (VD):  0.444
Pgp-substrate:  7.930178165435791%

ADMET: Metabolism

CYP1A2-inhibitor:  0.026
CYP1A2-substrate:  0.51
CYP2C19-inhibitor:  0.014
CYP2C19-substrate:  0.3
CYP2C9-inhibitor:  0.106
CYP2C9-substrate:  0.245
CYP2D6-inhibitor:  0.011
CYP2D6-substrate:  0.125
CYP3A4-inhibitor:  0.261
CYP3A4-substrate:  0.071

ADMET: Excretion

Clearance (CL):  2.243
Half-life (T1/2):  0.676

ADMET: Toxicity

hERG Blockers:  0.022
Human Hepatotoxicity (H-HT):  0.958
Drug-inuced Liver Injury (DILI):  0.959
AMES Toxicity:  0.248
Rat Oral Acute Toxicity:  0.713
Maximum Recommended Daily Dose:  0.887
Skin Sensitization:  0.57
Carcinogencity:  0.784
Eye Corrosion:  0.009
Eye Irritation:  0.015
Respiratory Toxicity:  0.966

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC34768

Natural Product ID:  NPC34768
Common Name*:   6Alpha,8Alpha-Dihydroxy-23-Carbossi-Labd-13(14),15,17-Trien-16,19-Olide
IUPAC Name:   (1R,4aS,5R,6R,8S,8aR)-6,8-dihydroxy-1,4a,6-trimethyl-5-[(E,5Z)-3-methyl-5-(3-methyl-5-oxofuran-2-ylidene)pent-3-enyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid
Synonyms:  
Standard InCHIKey:  ZZIIUCYVTHXMHB-HXHNTWCGSA-N
Standard InCHI:  InChI=1S/C25H36O6/c1-15(7-9-18-16(2)13-20(27)31-18)8-10-19-23(3)11-6-12-24(4,22(28)29)21(23)17(26)14-25(19,5)30/h7,9,13,17,19,21,26,30H,6,8,10-12,14H2,1-5H3,(H,28,29)/b15-7+,18-9-/t17-,19+,21+,23+,24+,25+/m0/s1
SMILES:  C/C(=CC=C/1C(=CC(=O)O1)C)/CC[C@@H]1[C@@]2(C)CCC[C@](C)([C@@H]2[C@H](C[C@@]1(C)O)O)C(=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL496193
PubChem CID:   44157612
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001538] Diterpene lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33075 salvia dominica Species Lamiaceae Eukaryota aerial parts n.a. n.a. PMID[19459643]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6478 Individual Protein Tubulin--tyrosine ligase Homo sapiens Kd = 93.0 nM PMID[492101]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC34768 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9697 High Similarity NPC179380
0.95 High Similarity NPC302788
0.949 High Similarity NPC476081
0.9381 High Similarity NPC278673
0.92 High Similarity NPC120321
0.9118 High Similarity NPC187435
0.9118 High Similarity NPC67321
0.8878 High Similarity NPC276110
0.8846 High Similarity NPC306265
0.8812 High Similarity NPC471412
0.8788 High Similarity NPC234993
0.8788 High Similarity NPC134072
0.875 High Similarity NPC475074
0.8725 High Similarity NPC162973
0.8713 High Similarity NPC471413
0.8713 High Similarity NPC47024
0.8679 High Similarity NPC478209
0.8673 High Similarity NPC139692
0.8654 High Similarity NPC266570
0.8654 High Similarity NPC471206
0.8654 High Similarity NPC478208
0.86 High Similarity NPC16967
0.8586 High Similarity NPC105490
0.8544 High Similarity NPC469606
0.8544 High Similarity NPC273005
0.8544 High Similarity NPC155332
0.8544 High Similarity NPC32577
0.8544 High Similarity NPC165250
0.8544 High Similarity NPC31058
0.8544 High Similarity NPC114540
0.8529 High Similarity NPC38855
0.8485 Intermediate Similarity NPC7349
0.8482 Intermediate Similarity NPC41123
0.8482 Intermediate Similarity NPC145074
0.8482 Intermediate Similarity NPC114939
0.8476 Intermediate Similarity NPC469607
0.8476 Intermediate Similarity NPC478052
0.8468 Intermediate Similarity NPC146786
0.8462 Intermediate Similarity NPC45897
0.8462 Intermediate Similarity NPC112009
0.844 Intermediate Similarity NPC474271
0.844 Intermediate Similarity NPC478212
0.8431 Intermediate Similarity NPC216478
0.8431 Intermediate Similarity NPC57079
0.8431 Intermediate Similarity NPC108368
0.8416 Intermediate Similarity NPC29952
0.8416 Intermediate Similarity NPC242848
0.8411 Intermediate Similarity NPC137911
0.8411 Intermediate Similarity NPC228477
0.8411 Intermediate Similarity NPC478210
0.84 Intermediate Similarity NPC191521
0.8367 Intermediate Similarity NPC174342
0.8365 Intermediate Similarity NPC109195
0.8365 Intermediate Similarity NPC475038
0.835 Intermediate Similarity NPC54705
0.8333 Intermediate Similarity NPC175351
0.8333 Intermediate Similarity NPC478211
0.8333 Intermediate Similarity NPC51499
0.8333 Intermediate Similarity NPC132753
0.8333 Intermediate Similarity NPC151681
0.8333 Intermediate Similarity NPC473963
0.8333 Intermediate Similarity NPC121402
0.8333 Intermediate Similarity NPC224356
0.8318 Intermediate Similarity NPC50124
0.8318 Intermediate Similarity NPC275539
0.8318 Intermediate Similarity NPC189075
0.8317 Intermediate Similarity NPC259042
0.8317 Intermediate Similarity NPC157686
0.8302 Intermediate Similarity NPC81630
0.83 Intermediate Similarity NPC205034
0.83 Intermediate Similarity NPC162615
0.83 Intermediate Similarity NPC152778
0.8288 Intermediate Similarity NPC471816
0.8286 Intermediate Similarity NPC471208
0.8286 Intermediate Similarity NPC180204
0.8286 Intermediate Similarity NPC329345
0.8286 Intermediate Similarity NPC23584
0.8286 Intermediate Similarity NPC473283
0.8286 Intermediate Similarity NPC478057
0.8286 Intermediate Similarity NPC475526
0.8283 Intermediate Similarity NPC78973
0.8273 Intermediate Similarity NPC471204
0.8269 Intermediate Similarity NPC115899
0.8269 Intermediate Similarity NPC303559
0.8269 Intermediate Similarity NPC11974
0.8257 Intermediate Similarity NPC132790
0.8257 Intermediate Similarity NPC469655
0.8257 Intermediate Similarity NPC247031
0.8257 Intermediate Similarity NPC100329
0.8257 Intermediate Similarity NPC474846
0.8257 Intermediate Similarity NPC469656
0.8257 Intermediate Similarity NPC97939
0.8252 Intermediate Similarity NPC325229
0.8252 Intermediate Similarity NPC275086
0.8247 Intermediate Similarity NPC131813
0.8241 Intermediate Similarity NPC475065
0.8241 Intermediate Similarity NPC284828
0.8241 Intermediate Similarity NPC5475
0.8241 Intermediate Similarity NPC173905
0.8241 Intermediate Similarity NPC472216
0.8235 Intermediate Similarity NPC93245
0.8235 Intermediate Similarity NPC154526
0.8235 Intermediate Similarity NPC472362
0.8235 Intermediate Similarity NPC473964
0.8235 Intermediate Similarity NPC202833
0.8235 Intermediate Similarity NPC472363
0.8224 Intermediate Similarity NPC329048
0.8224 Intermediate Similarity NPC330011
0.8224 Intermediate Similarity NPC110496
0.8224 Intermediate Similarity NPC143609
0.8218 Intermediate Similarity NPC57117
0.8218 Intermediate Similarity NPC24861
0.8218 Intermediate Similarity NPC225474
0.8218 Intermediate Similarity NPC469596
0.8218 Intermediate Similarity NPC148000
0.8214 Intermediate Similarity NPC478204
0.8205 Intermediate Similarity NPC476008
0.82 Intermediate Similarity NPC72845
0.819 Intermediate Similarity NPC11956
0.819 Intermediate Similarity NPC472552
0.8182 Intermediate Similarity NPC44537
0.8182 Intermediate Similarity NPC470063
0.8173 Intermediate Similarity NPC266955
0.8173 Intermediate Similarity NPC474012
0.8173 Intermediate Similarity NPC476767
0.8173 Intermediate Similarity NPC201406
0.8173 Intermediate Similarity NPC476299
0.8173 Intermediate Similarity NPC16601
0.8173 Intermediate Similarity NPC117685
0.8173 Intermediate Similarity NPC251680
0.8173 Intermediate Similarity NPC324841
0.8173 Intermediate Similarity NPC470074
0.8165 Intermediate Similarity NPC12795
0.8165 Intermediate Similarity NPC16270
0.8165 Intermediate Similarity NPC177047
0.8165 Intermediate Similarity NPC472666
0.8158 Intermediate Similarity NPC184555
0.8155 Intermediate Similarity NPC53844
0.8155 Intermediate Similarity NPC91695
0.8155 Intermediate Similarity NPC110937
0.8155 Intermediate Similarity NPC100912
0.8155 Intermediate Similarity NPC136781
0.8155 Intermediate Similarity NPC70145
0.8148 Intermediate Similarity NPC325054
0.8148 Intermediate Similarity NPC475418
0.8148 Intermediate Similarity NPC318363
0.8148 Intermediate Similarity NPC476479
0.8148 Intermediate Similarity NPC473482
0.8148 Intermediate Similarity NPC137462
0.8148 Intermediate Similarity NPC102843
0.8148 Intermediate Similarity NPC304276
0.8142 Intermediate Similarity NPC478205
0.8142 Intermediate Similarity NPC478206
0.8142 Intermediate Similarity NPC108581
0.8137 Intermediate Similarity NPC183012
0.8137 Intermediate Similarity NPC266899
0.8131 Intermediate Similarity NPC252296
0.8131 Intermediate Similarity NPC477125
0.8131 Intermediate Similarity NPC189863
0.8131 Intermediate Similarity NPC111952
0.8131 Intermediate Similarity NPC218158
0.8125 Intermediate Similarity NPC469794
0.8125 Intermediate Similarity NPC72772
0.812 Intermediate Similarity NPC477745
0.8119 Intermediate Similarity NPC472640
0.8119 Intermediate Similarity NPC110022
0.8119 Intermediate Similarity NPC472641
0.8113 Intermediate Similarity NPC159533
0.8113 Intermediate Similarity NPC120009
0.8113 Intermediate Similarity NPC36688
0.8113 Intermediate Similarity NPC187302
0.8113 Intermediate Similarity NPC196471
0.8113 Intermediate Similarity NPC471938
0.8113 Intermediate Similarity NPC476848
0.8113 Intermediate Similarity NPC189588
0.8113 Intermediate Similarity NPC72151
0.8113 Intermediate Similarity NPC291154
0.8113 Intermediate Similarity NPC97487
0.8113 Intermediate Similarity NPC10232
0.8108 Intermediate Similarity NPC469463
0.8108 Intermediate Similarity NPC475966
0.8108 Intermediate Similarity NPC469454
0.8108 Intermediate Similarity NPC171126
0.8108 Intermediate Similarity NPC469496
0.8108 Intermediate Similarity NPC25909
0.8103 Intermediate Similarity NPC55602
0.81 Intermediate Similarity NPC280149
0.81 Intermediate Similarity NPC310479
0.81 Intermediate Similarity NPC232202
0.81 Intermediate Similarity NPC472642
0.81 Intermediate Similarity NPC221111
0.8095 Intermediate Similarity NPC282524
0.8095 Intermediate Similarity NPC235142
0.8095 Intermediate Similarity NPC168319
0.8095 Intermediate Similarity NPC194028
0.8095 Intermediate Similarity NPC472554
0.8081 Intermediate Similarity NPC104560
0.8081 Intermediate Similarity NPC472302
0.8081 Intermediate Similarity NPC93411
0.8081 Intermediate Similarity NPC106332

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC34768 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8252 Intermediate Similarity NPD7638 Approved
0.8173 Intermediate Similarity NPD7640 Approved
0.8173 Intermediate Similarity NPD7639 Approved
0.8073 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD6686 Approved
0.7736 Intermediate Similarity NPD4225 Approved
0.7727 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7653 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7642 Intermediate Similarity NPD7902 Approved
0.7636 Intermediate Similarity NPD6402 Approved
0.7636 Intermediate Similarity NPD5739 Approved
0.7636 Intermediate Similarity NPD7128 Approved
0.7636 Intermediate Similarity NPD6675 Approved
0.7589 Intermediate Similarity NPD6372 Approved
0.7589 Intermediate Similarity NPD6373 Approved
0.7586 Intermediate Similarity NPD7115 Discovery
0.7524 Intermediate Similarity NPD7748 Approved
0.7523 Intermediate Similarity NPD7632 Discontinued
0.7521 Intermediate Similarity NPD7507 Approved
0.75 Intermediate Similarity NPD7515 Phase 2
0.75 Intermediate Similarity NPD6881 Approved
0.75 Intermediate Similarity NPD7320 Approved
0.75 Intermediate Similarity NPD6899 Approved
0.748 Intermediate Similarity NPD7319 Approved
0.7456 Intermediate Similarity NPD6650 Approved
0.7456 Intermediate Similarity NPD6649 Approved
0.7429 Intermediate Similarity NPD6399 Phase 3
0.7411 Intermediate Similarity NPD5701 Approved
0.7411 Intermediate Similarity NPD5697 Approved
0.7391 Intermediate Similarity NPD6053 Discontinued
0.7373 Intermediate Similarity NPD7328 Approved
0.7373 Intermediate Similarity NPD7327 Approved
0.7368 Intermediate Similarity NPD7102 Approved
0.7368 Intermediate Similarity NPD7290 Approved
0.7368 Intermediate Similarity NPD6883 Approved
0.7358 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD7900 Approved
0.7353 Intermediate Similarity NPD3618 Phase 1
0.7345 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7503 Approved
0.7333 Intermediate Similarity NPD7637 Suspended
0.7315 Intermediate Similarity NPD6083 Phase 2
0.7315 Intermediate Similarity NPD6084 Phase 2
0.7311 Intermediate Similarity NPD7516 Approved
0.7304 Intermediate Similarity NPD6869 Approved
0.7304 Intermediate Similarity NPD6847 Approved
0.7304 Intermediate Similarity NPD8130 Phase 1
0.7304 Intermediate Similarity NPD6617 Approved
0.7281 Intermediate Similarity NPD6014 Approved
0.7281 Intermediate Similarity NPD6012 Approved
0.7281 Intermediate Similarity NPD6013 Approved
0.7264 Intermediate Similarity NPD5778 Approved
0.7264 Intermediate Similarity NPD5779 Approved
0.7255 Intermediate Similarity NPD1694 Approved
0.7241 Intermediate Similarity NPD8297 Approved
0.7241 Intermediate Similarity NPD6882 Approved
0.7193 Intermediate Similarity NPD6011 Approved
0.719 Intermediate Similarity NPD8380 Approved
0.719 Intermediate Similarity NPD8379 Approved
0.719 Intermediate Similarity NPD8335 Approved
0.719 Intermediate Similarity NPD8378 Approved
0.719 Intermediate Similarity NPD8296 Approved
0.7182 Intermediate Similarity NPD6648 Approved
0.717 Intermediate Similarity NPD8034 Phase 2
0.717 Intermediate Similarity NPD8035 Phase 2
0.7168 Intermediate Similarity NPD6008 Approved
0.7157 Intermediate Similarity NPD7338 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD4755 Approved
0.7155 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5328 Approved
0.7117 Intermediate Similarity NPD5344 Discontinued
0.7107 Intermediate Similarity NPD8377 Approved
0.7107 Intermediate Similarity NPD8294 Approved
0.7103 Intermediate Similarity NPD4202 Approved
0.7091 Intermediate Similarity NPD5696 Approved
0.7075 Intermediate Similarity NPD46 Approved
0.7075 Intermediate Similarity NPD6698 Approved
0.7059 Intermediate Similarity NPD6695 Phase 3
0.7054 Intermediate Similarity NPD5211 Phase 2
0.7049 Intermediate Similarity NPD8033 Approved
0.7034 Intermediate Similarity NPD4632 Approved
0.7027 Intermediate Similarity NPD5285 Approved
0.7027 Intermediate Similarity NPD4700 Approved
0.7027 Intermediate Similarity NPD5286 Approved
0.7027 Intermediate Similarity NPD4696 Approved
0.7019 Intermediate Similarity NPD7521 Approved
0.7019 Intermediate Similarity NPD7334 Approved
0.7019 Intermediate Similarity NPD6409 Approved
0.7019 Intermediate Similarity NPD6684 Approved
0.7019 Intermediate Similarity NPD5330 Approved
0.7019 Intermediate Similarity NPD7146 Approved
0.7009 Intermediate Similarity NPD5284 Approved
0.7009 Intermediate Similarity NPD6411 Approved
0.7009 Intermediate Similarity NPD5281 Approved
0.7009 Intermediate Similarity NPD6079 Approved
0.6972 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6972 Remote Similarity NPD5695 Phase 3
0.6967 Remote Similarity NPD6319 Approved
0.6957 Remote Similarity NPD6412 Phase 2
0.693 Remote Similarity NPD5141 Approved
0.6923 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6371 Approved
0.6917 Remote Similarity NPD6274 Approved
0.6909 Remote Similarity NPD4697 Phase 3
0.6903 Remote Similarity NPD5225 Approved
0.6903 Remote Similarity NPD4633 Approved
0.6903 Remote Similarity NPD5224 Approved
0.6903 Remote Similarity NPD5226 Approved
0.6891 Remote Similarity NPD8133 Approved
0.6887 Remote Similarity NPD5737 Approved
0.6887 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6887 Remote Similarity NPD6672 Approved
0.6887 Remote Similarity NPD6903 Approved
0.6885 Remote Similarity NPD7101 Approved
0.6885 Remote Similarity NPD7100 Approved
0.6881 Remote Similarity NPD5282 Discontinued
0.688 Remote Similarity NPD7492 Approved
0.686 Remote Similarity NPD6009 Approved
0.6852 Remote Similarity NPD5693 Phase 1
0.6842 Remote Similarity NPD5174 Approved
0.6842 Remote Similarity NPD5175 Approved
0.6838 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6829 Remote Similarity NPD6059 Approved
0.6829 Remote Similarity NPD6054 Approved
0.6827 Remote Similarity NPD4786 Approved
0.6827 Remote Similarity NPD3666 Approved
0.6827 Remote Similarity NPD3665 Phase 1
0.6827 Remote Similarity NPD3133 Approved
0.6825 Remote Similarity NPD6616 Approved
0.6822 Remote Similarity NPD6101 Approved
0.6822 Remote Similarity NPD4753 Phase 2
0.6822 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6822 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6818 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6814 Remote Similarity NPD5223 Approved
0.6803 Remote Similarity NPD6335 Approved
0.68 Remote Similarity NPD7604 Phase 2
0.68 Remote Similarity NPD8328 Phase 3
0.6796 Remote Similarity NPD3667 Approved
0.6792 Remote Similarity NPD7750 Discontinued
0.6792 Remote Similarity NPD3573 Approved
0.6792 Remote Similarity NPD7524 Approved
0.6786 Remote Similarity NPD8029 Clinical (unspecified phase)
0.678 Remote Similarity NPD4634 Approved
0.6774 Remote Similarity NPD6908 Approved
0.6774 Remote Similarity NPD5983 Phase 2
0.6774 Remote Similarity NPD8513 Phase 3
0.6774 Remote Similarity NPD6909 Approved
0.6774 Remote Similarity NPD8516 Approved
0.6774 Remote Similarity NPD8517 Approved
0.6774 Remote Similarity NPD8515 Approved
0.6772 Remote Similarity NPD7078 Approved
0.6772 Remote Similarity NPD8293 Discontinued
0.6765 Remote Similarity NPD6931 Approved
0.6765 Remote Similarity NPD7525 Registered
0.6765 Remote Similarity NPD6930 Phase 2
0.6759 Remote Similarity NPD7838 Discovery
0.6759 Remote Similarity NPD5785 Approved
0.6757 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6757 Remote Similarity NPD5222 Approved
0.6757 Remote Similarity NPD5221 Approved
0.6731 Remote Similarity NPD7154 Phase 3
0.6724 Remote Similarity NPD4767 Approved
0.6724 Remote Similarity NPD4768 Approved
0.6721 Remote Similarity NPD6317 Approved
0.672 Remote Similarity NPD6370 Approved
0.6719 Remote Similarity NPD7736 Approved
0.6698 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6698 Remote Similarity NPD5279 Phase 3
0.6697 Remote Similarity NPD6050 Approved
0.6696 Remote Similarity NPD4754 Approved
0.6696 Remote Similarity NPD5173 Approved
0.6693 Remote Similarity NPD6336 Discontinued
0.6692 Remote Similarity NPD7260 Phase 2
0.6667 Remote Similarity NPD4629 Approved
0.6667 Remote Similarity NPD6314 Approved
0.6667 Remote Similarity NPD6904 Approved
0.6667 Remote Similarity NPD6080 Approved
0.6667 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6051 Approved
0.6667 Remote Similarity NPD6313 Approved
0.6667 Remote Similarity NPD5210 Approved
0.6667 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6929 Approved
0.6667 Remote Similarity NPD6673 Approved
0.664 Remote Similarity NPD6921 Approved
0.664 Remote Similarity NPD6016 Approved
0.664 Remote Similarity NPD6015 Approved
0.664 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6639 Remote Similarity NPD6868 Approved
0.661 Remote Similarity NPD5128 Approved
0.661 Remote Similarity NPD4730 Approved
0.661 Remote Similarity NPD4729 Approved
0.6606 Remote Similarity NPD5692 Phase 3
0.6606 Remote Similarity NPD5207 Approved
0.6602 Remote Similarity NPD7332 Phase 2
0.6602 Remote Similarity NPD7514 Phase 3
0.66 Remote Similarity NPD8039 Approved
0.6587 Remote Similarity NPD5988 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data